Background: No gold standard exists for the management of postoperative pain following anterior cruciate ligament reconstruction (ACLR). We compared the pain scores and medication use of patients undergoing single-bundle (SB) or double-bundle (DB) ACLR in the acute postoperative period. Pain and medication use was also analyzed for spinal versus general anesthesia approaches within both surgery types.
T
he anterior cruciate ligament (ACL) is the most commonly injured knee ligament, with approximately 200 000 ruptures annually in the United States. 1 Two common surgical approaches to treat the ACLdeficient knee are the single-bundle (SB) and anatomic double-bundle (DB) reconstruction methods. To our knowledge, no studies have been published to date comparing pain and medication use for the SB and DB ACL reconstruction (ACLR) procedures or comparing pain scores in the acute postoperative period for spinal versus general anesthesia approaches for these procedures.
No gold standard exists for the management of postoperative pain following ACLR. 2 Postoperative pain is often overlooked even though prevention and effective relief of acute pain can improve clinical outcomes, avoid clinical complications, save health care resources and improve quality of life. 3 Managing postoperative pain is also important because research has shown that early control of pain can assist with managing its evolution and development. 4 Previous studies have analyzed the effects of pain and rehabilitation for SB ACLR surgery and reported that postoperative patients who were unable to perform straight leg raises had significantly higher pain scores than patients who were able to perform straight leg raises. 5 These findings suggest that pain may inhibit function, limit early rehabilitation and delay recovery in the long-term. 5 The purpose of this quality assurance study was to compare postoperative pain scores and medication use between patients undergoing SB or DB ACLR and to determine if there was a difference in pain scores between patients receiving spinal anesthesia and those receiving general anesthesia for either SB or DB ACLR.
METHODS
We followed patients undergoing primary ACLR for 14 days postoperatively. All patients were assessed by 1 of 3 surgeons (L.A.H., S.M.H., G.M.B.) at the Banff Sport Medicine Clinic. The diagnosis of ACL deficiency was confirmed via a thorough history and clinical examination, including diagnostic imaging as necessary. Reconstruction surgery options were discussed with each patient. Patients considered for DB ACLR included those with a grade 3 pivot shift, athletes involved in high-demand pivoting sports and individuals likely to have a large ACL footprint. The final decision was made intraoperatively, as patients with inadequate-sized tendons or footprint areas were not suitable for DB ACLR.
The patients who underwent SB ACLR had previously been enrolled in a double-blind randomized controlled trial (RCT) in which pain and medication use was recorded for 14 days postoperatively (15 d in total). 6 We consecutively enrolled the patients in the DB ACLR group in a case series and recorded pain and medication use in the same manner as the RCT to assess appropriate provision of postoperative analgesia. We excluded patients undergoing revision surgery or reconstruction with allograft from our study.
All patients in the SB cohort received a primary anatomic ACLR with hamstring tendon autograft. The DB autograft ACLR was performed, as described by Hensler and colleagues, 7 with semitendinosus and gracilis tendons using a 2-tunnel technique. All surgeries were conducted under spinal or general anesthesia after consultation among the surgeon, patient and anesthesiologist.
At the time of discharge, all patients in the SB and DB ACLR cohorts were provided with a prescription for either 30 Percocet tablets (325 mg acetaminophen plus 5 mg oxycodone) or 30 Tylenol No. 3 tablets (325 mg acetaminophen plus 30 mg codeine) along with 30 Naproxen tablets (500 mg naprosyn). Patients were advised to take the Percocet or Tylenol No. 3 every 4 hours as required for pain management and the Naproxen twice daily (morning and evening) to help reduce the swelling and inflammation. Patients were also advised they could use regular Tylenol (acetaminophen 325 mg) for pain management.
Pain and medication logbook
Visual analogue scale (VAS) pain scores and medication use were recorded by each patient in a standard logbook 
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Statistical analysis
Data were entered and analyzed using SPSS software version 17 (SPSS Inc.). We performed unpaired t tests to compare pain scores between the SB and DB cohorts and the spinal and general anesthesia groups and to compare the duration of surgery between the SB and DB procedures. We compared medication use between the groups over the total 15-day period using a paired t test. All tests of significance were 2-sided, and we considered results to be significant at p < 0.05. For pain scores, we calculated 95% confidence intervals (CIs) of the difference of the mean.
RESULTS
Participants
In all, we followed 129 patients who underwent primary ACLR. A total of 88 patients (53 men, 35 women) underwent SB ACLR, and all of them returned pain and medication logbooks. The mean age of the SB cohort was 28.6 ± 5.8 years. A total of 67 patients underwent DB ACLR. Of these 67 patients, 26 underwent revision surgery or reconstruction with allograft and were not included in this study. All 41 eligible patients returned their logbooks. The mean age of the DB cohort was 24.7 ± 9.8 years. The DB operation was significantly longer than the SB procedure (74.8 ± 12.1 min v. 57 ± 11.8 min, p < 0.001).
Single-bundle versus double-bundle VAS pain scores
There was a significant difference in pain at 1 hour postsurgery, with a lower mean pain score in the SB cohort than the DB cohort (2.04 ± 2.2 v. 36.1 ± 29.6, p < 0.001; Table 1 ). For both procedures, VAS pain scores peaked at postoperative day 1 (8 pm), with a mean score of 43.7 ± 23 in the SB cohort and 49.3 ± 21 in the DB cohort. Afterwards, there was a decrease in VAS pain scores through postoperative day 14 for both cohorts (Fig. 1) . Over the entire 15-day period, the average VAS pain score in the DB cohort was 25.1 ± 8.6 compared with 23.9 ± 7.6 in the SB cohort, but this difference did not reach statistical significance. There were no significant differences in mean pain scores based on sex.
Single-bundle versus double-bundle medication use
Opioid use over the 15-day period peaked at postoperative day 1 for both procedures, with the SB cohort taking fewer pills than the DB cohort (mean 7.5 ± 3.0 v. 8.6 ± 2.5, p = 0.043). Afterwards, opioid use steadily declined for both procedures, with the lowest consumption observed on postoperative day 14 (Fig. 1) . Oral opioid medications were grouped for analysis, as 93% of patients in the DB cohort and 92% of patients in the SB cohort used Percocet as their primary pain relief medication. Comparing opioid use over the study period between the SB and DB procedures, significantly more opioids were consumed by the DB cohort from the day of surgery until postoperative day 14 (p = 0.011; Table 2 ).
The average number of pills consumed each day over the study period was lower in the SB than the DB cohort (2.8 ± 2.1 v. 3.5 ± 2.5; Table 2 ).
Maximum NSAID consumption occurred on postoperative day 1 for both procedures. There was no difference in NSAID consumption between the cohorts for the study period (Table 2 ). In contrast, acetaminophen consumption was significantly higher in the DB cohort than the SB cohort Can J Surg, Vol. 57, No. 3, June 2014 (mean of 0.77 ± 0.49 v. 0.3 ± 0.13, p = 0.001; Table 2 ). Maximum consumption of acetaminophen occurred on postoperative day 8 for the DB cohort (mean 1.41 ± 2.2 pills) and on postoperative day 6 for the SB cohort (mean 0.52 ± 2.0 pills).
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Spinal anesthesia versus general anesthesia VAS pain scores
In the SB cohort, 40 patients underwent spinal anesthesia and 39 patients underwent general anesthesia (Table 3) . Nine patients were converted from spinal anesthesia to general anesthesia; their pain scores were not included in this analysis. In the DB cohort, 21 patients underwent spinal anesthesia and 20 patients underwent general anesthesia (Table 4 ). Comparing spinal anesthesia with general anesthesia in both the SB and DB cohorts, there was a significant difference in VAS pain scores at 1-hour postsurgery, with patients who received spinal anesthesia reporting significantly lower scores (Tables 3 and 4 ). In the SB cohort, patients who received spinal anesthesia reported significantly more pain on postoperative day 1 (8 am) than those who had general anesthesia (p = 0.027; Table 3 , Fig. 2 ). For postoperative days 3-14, the SB spinal anesthesia group had a lower mean VAS pain score than the SB general anesthesia group. In the DB cohort, 6 of the 8 assessed time periods demonstrated significantly lower VAS pain scores for spinal than general anesthesia (Table 4) . On postoperative day 14, the DB spinal anesthesia group had a significantly lower mean VAS pain score than the DB general anesthesia group (7.2 ± 5.1 v. 18.1 ± 14.1, p < 0.001). As illustrated in Figure 3 , the mean pain scores of patients in the DB cohort who underwent spinal anesthesia compared with general anesthesia were lower over the entire study period.
Spinal anesthesia versus general anesthesia opioid use
In the DB cohort, opioid use was significantly higher in patients who underwent general anesthesia than spinal anesthesia over the study period (mean 3.9 ± 2.5 pills v. 3.1 ± 2.5 pills, p < 0.001; Table 5) .
DISCUSSION
This quality assurance study assessing pain scores and medication use was undertaken to identify if there was increased morbidity with respect to pain after DB compared with SB ACLR. Achieving optimal pain management of acute postoperative ACLR is important because pain has been shown to be related to clinical outcomes. 4 We analyzed and compared pain, medication use and type of anesthesia in these 2 independent cohorts. Patients in the DB cohort had increased pain in the first 2 weeks following ACLR, as evidenced by the significant difference in consumption of opioids and acetaminophen. Patients who received spinal anesthesia experienced less pain in the acute postoperative period than those who received general anesthesia.
For patients in both the SB and DB ACLR cohorts, pain and opioid use peaked in the evening of postoperative day 1 and then steadily decreased through postoperative day 14. Previous studies that analyzed pain and analgesia use associated with the SB ACLR procedure reported that both pain and narcotic use peaked on postoperative day 1, followed by a similar decline. 5, 8 Direct comparisons could not be made with our results, as previous authors used a different pain measurement scale; however, we observed similar trends.
Patients in the DB cohort followed similar pain score patterns, but demonstrated a trend toward higher mean pain scores across the postoperative period. The DB cohort consumed significantly more opioids and acetaminophen during the study. In the first 48 hours after surgery, patients appeared to self-medicate to a pain level of approximately 30 out of 100. We observed this trend in both patient cohorts; however, patients in the DB cohort required more opioid medication to achieve this pain score. Consumption of NSAIDs was similar between the cohorts throughout the study, possibly because patients were prescribed 1 week of NSAID medication and were following instructions rather than medicating for pain.
Despite the previous lack of data assessing pain scores for the DB ACLR procedure, the significantly greater postoperative opioid use in the DB cohort discovered in this study is not surprising. The DB procedure requires the drilling of an additional tunnel on both the femur and tibia. 7, 9 The tibial tunnel for the posterolateral bundle is farther posterior and requires more dissection of the anteromedial tibia. This tunnel also goes through thicker cortical bone, which may cause more thermal damage due to drilling and may be a source of greater pain. Another factor that is quite often overlooked in terms of pain levels is the psychological aspect of surgery, including the patient's expectations regarding postsurgical pain. On this basis, patients who underwent a DB procedure may have interpreted this as undergoing more extensive surgery.
The only significant difference in VAS pain scores between the SB and DB cohorts occurred at 1 hour postsurgery. If there had been uneven numbers of patients in the spinal anesthesia compared with general anesthesia groups within each cohort, it could have influenced the results because spinal anesthesia provides postoperative analgesia whereas general anesthesia does not. 10 However, the spinal and general anesthesia approaches were equally distributed in both our cohorts; therefore, the method of anesthesia does not explain the difference in VAS pain scores that we observed at this time point. In addition, patients in the DB cohort who received spinal anesthesia recorded significantly greater pain scores 1 hour postoperative than patients in the SB cohort who received spinal anesthesia. This discrepancy is likely related to the duration of the procedures. The DB procedure was significantly longer than the SB procedure, leading to medications administered during surgery being less effective in the DB group by 1 hour postsurgery, thereby resulting in significantly higher pain scores.
For both the SB and DB procedures, the general trend was that patients who received spinal anesthesia experienced less pain over the study period than patients who received general anesthesia. This difference in pain was far more significant in the DB cohort. This trend is consistent with previous studies that demonstrated spinal anesthesia provided longer-term pain relief than general anesthesia for common orthopedic procedures. 10, 11 It has been suggested that this phenomenon can be explained by the pre-emptive analgesic effect of the spinal anesthetic. 
Limitations
There are several limitations to this study. We analyzed 2 independent cohorts, and no randomization was performed. Selection bias did exist, as the patients in the DB cohort were selected for surgery for a variety of reasons, including degree of pivotal laxity, athletic endeavours and patient size. In addition, there was no randomization of the anesthesia procedure. With any pain study, the manifestation as well as the interpretation of pain scores is subjective and highly variable among patients. In addition, the correlation of statistically significant differences in the VAS pain scores to clinically important differences has yet to be determined. Despite these limitations postoperative pain plays such an important role in each patient's recovery and well-being that any potential for improved postoperative pain management merits investigation. Also, the pain scale used in our study, the VAS, is one of the oldest, easiest and best validated measures to assess pain. 13 The results of our study provide useful clinical information about the differences in pain scores and medication use between SB and DB ACLR.
CONCLUSION
This quality assurance study demonstrated that adequate pain relief was provided to all ACLR patients in the initial postoperative period. Patients in the DB cohort had increased pain postoperatively, as evidenced by the signifi cant difference in consumption of opioids and acetaminophen. Patients who received spinal anesthesia experienced less pain over the initial 14-day postoperative period than patients who received general anesthesia. This perioperative morbidity should be considered when deciding on the risks and benefits of ACLR surgical procedures. These findings may be clinically important, as higher postoperative pain scores have been linked to lower functional outcomes and quality of life scores. Further investigation of the effect of acute postoperative pain on functional outcome is warranted for both the SB and DB ACLR procedures.
